Remembering Bonnie Mathieson: A champion of young scientists

The battle against HIV/AIDS lost another great soldier recently with the passing of Australian immunologist and clinician David Cooper on March 18. Cooper was a pioneering scientist and champion for HIV treatment and prevention, and he left an indelible mark on the field he dedicated his career to. “He had a great skill in knowing…

Jonathan Quick describes how the right mix of science, funding, leadership, and communication can come together to secure the world against future epidemics.

Influenza, like HIV, is a highly variable menace. A particularly bad flu season has researchers seeking ways to make a better vaccine, and in doing so, there may be lessons from, and for, HIV vaccine research.

Several areas of progress in using antibodies for HIV prevention were showcased at the recent Keystone Symposia.

We are at a defining moment in the history of HIV vaccine research. It is not an exaggeration to also propose that, thanks to the fruits of decades of HIV vaccine research and development efforts, we are entering a new era of vaccinology more broadly. A new generation of HIV vaccine candidates is poised to…

Coalition awards US$174 million in grants for research targeting Nipah virus, Lassa fever, and MERS.

Africa is contributing far more than samples to scientific research. The continent’s scientists are actively engaged in developing and testing novel HIV vaccine candidates.

A conversation with Anatoli Kamali and Penny Moore about the rise of HIV vaccine science in Africa

This year’s flu season was one for the books, and it swung the spotlight directly on vaccines. The predominant strain of influenza virus that circulated in the US, an influenza A subtype known as H3N2, was particularly virulent, leaving thousands dead and sending many more to the hospital. And the seasonal flu vaccine was only…